E3 PreliminaryPreliminaryPEM not requiredCross-SectionalPeer-reviewedMachine draft
Neuropathology in rhinosinusitis.
Baraniuk, James N, Petrie, Kristina Naranch, Le, Uyenphuong et al. · American journal of respiratory and critical care medicine · 2005 · DOI
Quick Summary
Researchers tested how the nasal passages of people with ME/CFS, sinusitis, allergies, and healthy controls responded to salt water spray. They found that people with ME/CFS experienced unusual nerve sensitivity (feeling more pain) but their mucus-producing glands didn't respond normally to the stimulus. This suggests that ME/CFS involves a different pattern of how nerves and mucus glands work in the nose compared to other nasal conditions.
Why It Matters
This study provides mechanistic evidence that ME/CFS involves abnormal neural-mucosal interactions distinct from allergic or infectious rhinitis. Understanding these neuropathologic differences in ME/CFS could inform development of targeted treatments and validate that ME/CFS involves real, measurable biological dysfunction in nerve and gland responses.
Observed Findings
- CFS subjects demonstrated neural hypersensitivity (elevated pain, blockage, and drip sensations with HTS) compared to normal controls
- CFS subjects showed reduced serous cell secretion (urea response) despite neural activation
- Only allergic rhinitis and normal groups demonstrated mucin dose responses and correlations between symptoms and lysozyme secretion
- Sinusitis subjects showed nonneurogenic mucous hypersecretion with correlations between albumin and mucin concentrations
- Neural stimulation did not alter albumin (vascular) exudation in any group
Inferred Conclusions
- CFS involves a unique pattern of neural hypersensitivity combined with impaired secretory gland responsiveness, distinct from allergic rhinitis or sinusitis
- Different rhinosinusitis syndromes are driven by different pathophysiologic mechanisms (neurogenic versus nonneurogenic)
- The dysregulation in CFS suggests abnormal coupling between sensory neural activation and mucosal secretory responses
Remaining Questions
- Does this nasal neuropathology reflect generalized dysfunction in ME/CFS or is it specific to the respiratory tract?
- What are the underlying mechanisms causing reduced serous gland secretion despite intact neural sensitivity in ME/CFS?
What This Study Does Not Prove
This study does not establish causation or whether nasal neuropathology is primary to ME/CFS or secondary to other disease mechanisms. It does not demonstrate that treating nasal dysfunction will improve ME/CFS symptoms, nor does it clarify whether these findings generalize beyond the subset of ME/CFS patients with nonallergic rhinitis.
Tags
Symptom:PainSensory Sensitivity
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.1164/rccm.200403-357OC
- PMID
- 15477496
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →